Hsp104 Targets Multiple Intermediates on the Amyloid Pathway and Suppresses the Seeding Capacity of Aβ Fibrils and Protofibrils

Journal of Molecular Biology

Volumn 384, Issue 5, 2008, Pages 1157-1173

  Arimon, Muriel ^a,b   Grimminger, Valerie ^a   Sanz, Fausto ^b   Lashuel, Hilal A ^a  

^a EPFL   (Switzerland)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Alzheimer's disease; amyloid formation A ; disaggregation; Hsp104

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMYLOID; AMYLOID BETA PROTEIN; HEAT SHOCK PROTEIN 104;

ARTICLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; NONHUMAN; OLIGOMERIZATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN FUNCTION; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALIA; ESCHERICHIA COLI; MAMMALIA;

EID: 56949083650     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.09.063     Document Type: Article

References (50)

1. Lansbury P.T., and Lashuel H.A. A century-old debate on protein aggregation and neurodegeneration enters the clinic. Nature 443 (2006) 774-779
2. Shorter J., and Lindquist S. Hsp104 catalyzes formation and elimination of self-replicating Sup35 prion conformers. Science 304 (2004) 1793-1797
3. Shorter J., and Lindquist S. Destruction or potentiation of different prions catalyzed by similar Hsp104 remodeling activities. Mol. Cell 23 (2006) 425-438
4. Bösl B., Grimminger V., and Walter S. Substrate binding to the molecular chaperone Hsp104 and its regulation by nucleotides. J. Biol. Chem. 280 (2005) 38170-38176
5. Schaupp A., Marcinowski M., Grimminger V., Bösl B., and Walter S. Processing of proteins by the molecular chaperone Hsp104. J. Mol. Biol. 370 (2007) 674-686
6. Bösl B., Grimminger V., and Walter S. The molecular chaperone Hsp104-A molecular machine for protein disaggregation. J. Struct. Biol. 156 (2006) 139-148
7. Doyle S.M., Shorter J., Zolkiewski M., Hoskins J.R., Lindquist S., and Wickner S. Asymmetric deceleration of ClpB or Hsp104 ATPase activity unleashes protein-remodeling activity. Nat. Struct. Mol. Biol. 14 (2007) 114-122
8. Wendler P., Shorter J., Plisson C., Cashikar A.G., Lindquist S., and Saibil H.R. Atypical AAA+ subunit packing creates an expanded cavity for disaggregation by the protein-remodeling factor Hsp104. Cell 131 (2007) 1366-1377
9. Weibezahn J., Tessarz P., Schlieker C., Zahn R., Maglica Z., Lee S., et al. Thermotolerance requires refolding of aggregated proteins by substrate translocation through the central pore of ClpB. Cell 119 (2004) 653-665
10. Zolkiewski M. A camel passes through the eye of a needle: protein unfolding activity of Clp ATPases. Mol. Microbiol. 61 (2006) 1094-1100
11. Ben Zvi A.P., and Goloubinoff P. Mechanisms of disaggregation and refolding of stable protein aggregates by molecular chaperones. J. Struct. Biol. 135 (2001) 84-93
12. Glover J.R., and Lindquist S. Hsp104, Hsp70, and Hsp40: a novel chaperone system that rescues previously aggregated proteins. Cell 94 (1998) 73-82
13. Chernoff Y.O., Lindquist S.L., Ono B., Inge-Vechtomov S.G., and Liebman S.W. Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science 268 (1995) 880-884
14. Sanchez Y., and Lindquist S.L. HSP104 required for induced thermotolerance. Science 248 (1990) 1112-1115
15. Sanchez Y., Taulien J., Borkovich K.A., and Lindquist S. Hsp104 is required for tolerance to many forms of stress. EMBO J. 11 (1992) 2357-2364
16. Carmichael J., Chatellier J., Woolfson A., Milstein C., Fersht A.R., and Rubinsztein D.C. Bacterial and yeast chaperones reduce both aggregate formation and cell death in mammalian cell models of Huntington's disease. Proc. Natl Acad. Sci. USA 97 (2000) 9701-9705
17. Cashikar A.G., Duennwald M., and Lindquist S.L. A chaperone pathway in protein disaggregation. Hsp26 alters the nature of protein aggregates to facilitate reactivation by Hsp104. J. Biol. Chem. 280 (2005) 23869-23875
18. Perrin V., Regulier E., Abbas-Terki T., Hassig R., Brouillet E., Aebischer P., et al. Neuroprotection by Hsp104 and Hsp27 in lentiviral-based rat models of Huntington's disease. Mol. Ther. 15 (2007) 903-911
19. Satyal S.H., Schmidt E., Kitagawa K., Sondheimer N., Lindquist S., Kramer J.M., and Morimoto R.I. Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 97 (2000) 5750-5755
20. Vacher C., Garcia-Oroz L., and Rubinsztein D.C. Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington's disease. Hum. Mol. Genet. 14 (2005) 3425-3433
21. Kimura Y., Koitabashi S., Kakizuka A., and Fujita T. Initial process of polyglutamine aggregate formation in vivo. Genes Cells 6 (2001) 887-897
22. DebBurman S., Raymond G., Caughey B., and Lindquist S. Chaperone-supervised conversion of prion protein to its protease-resistant form. Proc. Natl. Acad. Sci. USA 94 (1997) 13938-13943
23. Schirmer E.C., and Lindquist S.L. Interactions of the chaperone Hsp104 with yeast Sup35 and mammalian PrP. Proc. Natl Acad. Sci. USA 94 (1997) 13932-13937
24. Lashuel H.A., and Grillo-Bosch D. In vitro preparation of prefibrillar intermediates of amyloid-beta and alpha-synuclein. Methods Mol. Biol. 299 (2005) 19-33
25. Jan A., Gokce O., Luthi-Carter R., and Lashuel H.A. The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of Aabeta aggregation, fibrillogenesis, and toxicity. J. Biol. Chem. 283 (2008) 28176-28189
26. Harper J.D., Lieber C.M., and Lansbury Jr. P.T. Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein. Chem. Biol. 4 (1997) 951-959
27. Harper J.D., Wong S.S., Lieber C.M., and Lansbury P.T. Observation of metastable Abeta amyloid protofibrils by atomic force microscopy. Chem. Biol. 4 (1997) 119-125
28. Walsh D.M., Lomakin A., Benedek G.B., Condron M.M., and Teplow D.B. Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J. Biol. Chem. 272 (1997) 22364-22372
29. Arimon M., Diez-Perez I., Kogan M.J., Durany N., Giralt E., Sanz F., and Fernandez-Busquets X. Fine structure study of Abeta1-42 fibrillogenesis with atomic force microscopy. FASEB J. 19 (2005) 1344-1346
30. Bitan G., Kirkitadze M.D., Lomakin A., Vollers S.S., Benedek G.B., and Teplow D.B. Amyloid beta-protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc. Natl Acad. Sci. USA 100 (2003) 330-335
31. Harper J.D., Wong S.S., Lieber C.M., and Lansbury Jr. P.T. Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease. Biochemistry 38 (1999) 8972-8980
32. Harper J.D., and Lansbury Jr. P.T. Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. Annu. Rev. Biochem. 66 (1997) 385-407
33. Jarrett J.T., and Lansbury Jr. P.T. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?. Cell 73 (1993) 1055-1058
34. Grimminger V., Richter K., Imhof A., Buchner J., and Walter S. The prion curing agent guanidinium chloride specifically inhibits ATP hydrolysis by Hsp104. J. Biol. Chem. 279 (2004) 7378-7383
35. Cashikar A.G., Schirmer E.C., Hattendorf D.A., Glover J.R., Ramakrishnan M.S., Ware D.M., and Lindquist S.L. Defining a pathway of communication from the C-terminal peptide binding domain to the N-terminal ATPase domain in a AAA protein. Mol. Cell 9 (2002) 751-760
36. Weibezahn J., Schlieker C., Bukau B., and Mogk A. Characterization of a trap mutant of the AAA+ chaperone ClpB. J. Biol. Chem. 278 (2003) 32608-32617
37. Barnett M.E., Nagy M., Kedzierska S., and Zolkiewski M. The amino-terminal domain of ClpB supports binding to strongly aggregated proteins. J. Biol. Chem. 280 (2005) 34940-34945
38. Schlieker C., Weibezahn J., Patzelt H., Tessarz P., Strub C., Zeth K., et al. Substrate recognition by the AAA+ chaperone ClpB. Nat. Struct. Mol. Biol. 11 (2004) 607-615
39. Goloubinoff P., Mogk A., Zvi A.P., Tomoyasu T., and Bukau B. Sequential mechanism of solubilization and refolding of stable protein aggregates by a bichaperone network. Proc. Natl Acad. Sci. USA 96 (1999) 13732-13737
40. Inoue Y., Taguchi H., Kishimoto A., and Yoshida M. Hsp104 binds to yeast Sup35 prion fiber but needs other factor(s) to sever it. J. Biol. Chem. 279 (2004) 52319-52323
41. Narayanan S., Bösl B., Walter S., and Reif B. Importance of low-oligomeric-weight species for prion propagation in the yeast prion system Sup35/Hsp104. Proc. Natl Acad. Sci. USA 100 (2003) 9286-9291
42. Kushnirov V.V., and Ter Avanesyan M.D. Structure and replication of yeast prions. Cell 94 (1998) 13-16
43. Ness F., Ferreira P., Cox B.S., and Tuite M.F. Guanidine hydrochloride inhibits the generation of prion "seeds" but not prion protein aggregation in yeast. Mol. Cell Biol. 22 (2002) 5593-5605
44. Paushkin S.V., Kushnirov V.V., Smirnov V.N., and Ter Avanesyan M.D. Propagation of the yeast prion-like [psi+] determinant is mediated by oligomerization of the SUP35-encoded polypeptide chain release factor. EMBO J. 15 (1996) 3127-3134
45. Satpute-Krishnan P., Langseth S.X., and Serio T.R. Hsp104-dependent remodeling of prion complexes mediates protein-only inheritance. PLoS Biol. 5 (2007) e24
46. Krobitsch S., and Lindquist S. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc. Natl Acad. Sci. USA 97 (2000) 1589-1594
47. von der Haar T., Josse L., Wright P., Zenthon J., and Tuite M.F. Development of a novel yeast cell-based system for studying the aggregation of Alzheimer's disease-associated Abeta peptides in vivo. Neurodegener. Dis. 4 (2007) 136-147
48. Schirmer E.C., and Lindquist S. Purification and properties of Hsp104 from yeast. Methods Enzymol. 290 (1998) 430-444
49. Lashuel H.A., Hartley D.M., Petre B.M., Wall J.S., Simon M.N., Walz T., and Lansbury Jr. P.T. Mixtures of wild-type and a pathogenic (E22G) form of Abeta40 in vitro accumulate protofibrils, including amyloid pores. J. Mol. Biol. 332 (2003) 795-808
50. Pace C.N., Vajdos F., Fee L., Grimsley G., and Gray T. How to measure and predict the molar absorption coefficient of a protein. Protein Sci. 4 (1995) 2411-2423